You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Central Serous Chorioretinopathy

Showing 26 - 50 of 7,469
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Optical Coherence Tomography Angiography and Central Serous

Completed
  • Central Serous Chorioretinopathy
  • Optical Coherence Tomography Angiography (OCT-A)
  • (no location specified)
May 10, 2019

Vascular Pathology in Eye Diseases Using Using Optical Coherence

Completed
  • Retinal Disease
  • optical coherence tomography angiography
  • Bern, Switzerland
    Inselspital Bern, Department of Ophthalmology
Nov 28, 2022

Age-Related Macular Degeneration Trial in Odessa, Kyiv, Mykolaiv (Subtenon injection of 40 mg triamcinolone acetonide,

Completed
  • Age-Related Macular Degeneration
  • Subtenon injection of 40 mg triamcinolone acetonide
  • +8 more
  • Odessa, Please Select, Ukraine
  • +3 more
Aug 21, 2022

Macular Edema, Radiation Retinopathy, Branch Retinal Vein Occlusion Trial in Palo Alto (Episcleral Dexamethasone)

Unknown status
  • Macular Edema
  • +6 more
  • Episcleral Dexamethasone
  • Palo Alto, California
    Stanford Medicine Ophthalmology
Oct 7, 2019

Central Serous Chorioretinopathy Trial (Selective retina therapy)

Completed
  • Central Serous Chorioretinopathy
  • Selective retina therapy
  • (no location specified)
Dec 29, 2018

Diabetic Maculopathy Trial in Winston-Salem (Spironolactone 50 mg)

Withdrawn
  • Diabetic Maculopathy
  • Spironolactone 50 mg
  • Winston-Salem, North Carolina
    Wake Forest Baptist Health
Jul 28, 2022

Ovarian Cancer Trial in Worldwide (VS-6766, VS-6766 and Defactinib)

Recruiting
  • Low Grade Ovarian Serous Adenocarcinoma
  • Ovarian Cancer
  • avutometinib (VS-6766)
  • avutometinib (VS-6766) and Defactinib
  • Scottsdale, Arizona
  • +46 more
Dec 29, 2022

Central Serous Chorioretinopathy Trial in Seongnam-si, Seoul (R:GEN Selective Retina Therapy)

Completed
  • Central Serous Chorioretinopathy
  • R:GEN Selective Retina Therapy
  • Seongnam-si, Korea, Republic of
  • +5 more
Nov 28, 2018

Macular Edema, Inherited Retinal Dystrophy, Laser Retinopathy Trial in Rome (subthreshold treatment with micropulsed laser)

Not yet recruiting
  • Macular Edema
  • +2 more
  • subthreshold treatment with micropulsed laser
  • Rome, RM, Italy
    IRCSS Fondazione G:B:Bietti
Jul 27, 2023

rOutine Using afLibERcept: Strict vs relAxed retreatmeNT Regimen

Completed
  • Age Related Macular Degeneration
  • Bern, Switzerland
  • +1 more
Nov 28, 2022

Central Serous Chorioretinopathy Trial in United States (25mg Eplerenone, Placebo)

Completed
Has Results
  • Central Serous Chorioretinopathy
  • 25mg Eplerenone
  • Placebo
  • Cherry Hill, New Jersey
  • +9 more
Oct 8, 2018

Retinal Vascular Trial in Milan (Dark chocolate, Milk Chocolate)

Completed
  • Retinal Vascular
  • Dark chocolate
  • Milk Chocolate
  • Milan, Italy
    Giuseppe Querques
Feb 6, 2022

Retinal Capillaries After Half-dose PDT Measured by OCTA in Eyes

Unknown status
  • Central Serous Chorioretinopathy
  • Half-dose photodynamic therapy
  • Guangzhou, Guangdong, China
  • +1 more
Sep 28, 2018

High-grade Serous Ovarian Carcinoma, Ovarian Carcinoma Trial in Worldwide (Pembrolizumab, Paclitaxel, Carboplatin)

Recruiting
  • High-grade Serous Ovarian Carcinoma
  • Ovarian Carcinoma
  • Pembrolizumab
  • +5 more
  • Aurora, Colorado
  • +37 more
Jan 19, 2023

Acute Central Serous Chorioretinopathy Trial in Guangzhou (577-MPL, 577-TL)

Completed
  • Acute Central Serous Chorioretinopathy
  • 577-MPL
  • 577-TL
  • Guangzhou, Guangdong, China
    Zhongshan Ophthalmic Center, Sun Yat-sen University
Aug 14, 2018

Retinitis Pigmentosa Trial in Ankara (Wharton's jelly derived mesenchymal stemcells, Magnovision)

Completed
  • Retinitis Pigmentosa
  • Wharton's jelly derived mesenchymal stemcells
  • Magnovision
  • Ankara, Gölbaşı, Turkey
  • +2 more
Mar 23, 2023

Diabetic Macular Edema, Branch Retinal Vein Occlusion, Chronic Central Serous Retinopathy Trial in Porto Alegre (Topcon Endpoint

Unknown status
  • Diabetic Macular Edema
  • +3 more
  • Topcon Endpoint Management
  • Porto Alegre, RS, Brazil
    Instituto de Oftalmologia Lavinsky
Nov 11, 2018

Central Serous Chorioretinopathy Trial in Buenos Aires, Tel Aviv (Brinzolamide Ophthalmic)

Unknown status
  • Central Serous Chorioretinopathy
  • Brinzolamide Ophthalmic
  • Buenos Aires, Argentina
  • +1 more
May 29, 2018

Central Serous Chorioretinopathy Trial in Boston (Eplerenone 50mg)

Completed
Has Results
  • Central Serous Chorioretinopathy
  • Eplerenone 50mg
  • Boston, Massachusetts
    New England Eye Center / Tufts Medical Center
Apr 17, 2018

Three-dimensional Choroidal Vascularity Index in Common Fundus

Recruiting
  • Choroid
  • no intervention
  • Wuhan, Hubei, China
    Renmin Hospital of Wuhan University
Mar 6, 2021

Uveitis Trial in Miami (Norflo Oro, Placebo for Norflo Oro)

Completed
Has Results
  • Uveitis
  • Norflo Oro
  • Placebo for Norflo Oro
  • Miami, Florida
    Bascom Palmer Eye Institute
Mar 25, 2022

Central Serous Chorioretinopathy, Tomography, Optical Coherence Trial in Beijing (OCTA-guided Photodynamic therapy, ICGA-guided

Completed
  • Central Serous Chorioretinopathy
  • Tomography, Optical Coherence
  • OCTA-guided Photodynamic therapy
  • ICGA-guided Photodynamic therapy
  • Beijing, Beijing, China
    People's Hospital of Peking University
Apr 14, 2018

Uterine Serous Carcinoma Trial in Worldwide (Adavosertib)

Active, not recruiting
  • Uterine Serous Carcinoma
  • Burbank, California
  • +26 more
Jan 10, 2023

Central Serous Chorioretinopathy Trial in Washington (Micropulse Laser Treatment, No treatment)

Terminated
Has Results
  • Central Serous Chorioretinopathy
  • Micropulse Laser Treatment
  • No treatment
  • Washington, District of Columbia
    George Washington University Medical Faculty Associates
Mar 1, 2018

Platinum-resistant Ovarian Cancer Trial in China (IN10018 in combination with PLD)

Recruiting
  • Platinum-resistant Ovarian Cancer
  • IN10018 in combination with PLD
  • Anyang, China
  • +6 more
Sep 20, 2022